Literature DB >> 2327551

Primary malignant lymphoma arising in postmastectomy lymphedema. Another facet of the Stewart-Treves syndrome.

E S d'Amore1, M R Wick, K R Geisinger, G Frizzera.   

Abstract

In rare cases, primary malignant lymphomas may arise in the soft tissues. Only one previous case has arisen in the context of chronic lymphedema. Because of the clinical appearance of such lesions, which resemble violaceous nodular or plaquelike tumors, they may be confused clinically with lymphedema-associated angiosarcomas occurring after radical mastectomy (Stewart-Treves syndrome). Furthermore, the histologic appearance of some lymphomas and angiosarcomas may also be similar. We studied two women with primary postmastectomy lymphedema-related malignant lymphoma in the soft tissues of the upper arm. These tumors arose 11 and 30 years, respectively, after radical removal of ductal mammary carcinomas. Histologically, one neoplasm mimicked metastatic carcinoma or epithelioid angiosarcoma; whereas the other was initially confused with a variety of pathologic entities, including vasculitis, epithelioid hemangioma, and malignant fibrous histiocytoma. The lymphoid nature of both lesions was confirmed by immunoreactivity for leukocyte common antigen in addition to the B-lymphocyte marker, L26. Conversely, vascular and epithelial determinants were absent. One patient's disease pursued an indolent course; she died of unknown causes but with no evidence of lymphoma at last follow-up. The second patient is currently in remission on chemotherapy. Awareness of the existence of lymphedema-related malignant lymphoma and familiarity with methods used for its distinction from epithelioid vascular sarcomas should prevent unnecessary surgery.

Entities:  

Mesh:

Year:  1990        PMID: 2327551     DOI: 10.1097/00000478-199005000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  3 in total

1.  The risk of angiosarcoma following primary breast cancer.

Authors:  W Cozen; L Bernstein; F Wang; M F Press; T M Mack
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

2.  Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.

Authors:  Takayuki Kimura; Makoto Sugaya; Tomonori Oka; Andrew Blauvelt; Hitoshi Okochi; Shinichi Sato
Journal:  Oncotarget       Date:  2015-07-20

3.  Mantle cell lymphoma relapsing at the lymphedematous arm.

Authors:  Giuseppina Massini; Stefan Hohaus; Francesco D'Alò; Valentina Bozzoli; Barbara Vannata; Luigi Maria Larocca; Luciana Teofili
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-02-16       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.